Towards an HIV Cure Advisory Board and Collaboration Group

Stakeholder’s Advisory Board

Name

Post / Region

Carl Dieffenbach

NIAID/NIH

Charu Kaushic

Canadian Institutes of Health Research

François Dabis

ANRS

Giulio Maria Corbelli

European AIDS Treatment Group (EATG)

Glaudina Loots

Department of Science & Technology, Cape Town

Glenda Gray

South African Medical Research Council

Gottfried Hirnschall

WHO

Marcus Low

Treatment Action Campaign (TAC)

Mark Dybul

Georgetown University Medical Center

Mark Harrington

Treatment Action Group (TAG)

Maureen Goodenow

NIH-OAR

Mitchell Warren

AVAC

Moses Supercharger Nsubuga

Stigmaless

Nina Russell

Bill & Melinda Gates Foundation

Paula Munderi

International Association of Providers of AIDS Care (IAPAC)

Peter Godfrey-Faussett

UNAIDS

Rowena Johnston

amfAR

Serawit Bruck Landais

Sidaction

Sharon Lewin

The Doherty Institute, University of Melbourne

Subhasree Sai Raghavan

SAATHII

Yiming Shao

CDC, China

 

Industry Collaboration Group

Name

Post / Region

Alan Landay

Rush University Medical Center, USA

Anna-Laura Ross

Unitaid, Switzerland

Bonnie Howell

Merck, USA

Brian Johns

GlaxoSmithKline, USA

Bryan Cobb

Roche, USA

Carey Hwang

Merck, USA

Carl Dieffenbach

NIAID/NIH, USA

Christine Rouzioux

University Paris Descartes/Hôpital Necker, France

Christos J Petropoulos

Monogram Biosciences, USA

David Margolis

University of North Carolina at Chapel Hill, USA

Deborah Persaud

John Hopkins University School of Medicine, USA

François Dabis

ANRS, France

Giuseppe Pantaleo

University of Lausanne, Switzerland

Guenter Kraus

Janssen, Belgium

Guido Poli

San Raffaele University and Scientific Institute, Italy

Guido Silvestri

Emory University, USA

Hans-Peter Kiem

Fred Hutchinson Cancer Research Center, USA

Harriett Robinson

GeoVax, USA

Jan van Lunzen

ViiV Healthcare, UK

Javier Martinez Picado

irsiCaixa Foundation, Spain

Jeff Sheehy

California Institute for Regenerative Medicine, USA

Jeffrey Safrit

NantKwest, USA

Jintanat Ananworanich

US Military HIV Research Program, USA

John Mellors

University of Pittsburgh, USA

Lars Østergaard

Aarhus University Hospital, Denmark

Lynda Dee

DARE CAB/amfAR Cure Institute CAB, USA

Maja Sommerfelt

Bionor Pharma, Norway

Michael Busch

Blood Systems Research Institute, USA

Michael Lederman

Case Western Reserve University, USA

Nikos Dedes

EATG/ITPC, Greece

Rama Amara

Emory University, USA

Robert Reinhard

Public/Global Health Consultant, Canada

Romas Geleziunas

Gilead Sciences, USA

Rowena Johnston

amfAR, USA

Sarah Palmer

University of Sydney, Australia

Sharon Lewin

Doherty Institute, University of Melbourne, Australia

Steven Deeks

University of California, San Francisco, USA

Tomas Cihlar

Gilead Sciences, USA

Tri Do

University of California, San Francisco, USA

Veronica Miller

Forum for Collaborative Research, USA

Yves Levy

Vaccine Research Institute/Inserm/ANRS, France

International Scientific Working Group

Steering Committee

Name

Post / Region

Jintanat Ananworanich

US Military HIV Research Programme

Françoise Barré-Sinoussi

Institut Pasteur & Inserm

Monsef Benkirane

Institute of Human Genetics

Steven Deeks

University of California, San Francisco

Sharon Lewin

Doherty Institute for Infection & Immunity, University of Melbourne

Anna Laura Ross

ANRS & IAS

Joseph Tucker

UNC – Project China

Subgroup 1: Molecular biology of HIV latency and shock strategies

Name

Post / Region

Monsef Benkirane*

Institute of Human Genetics, France

Eric Cohen

IRCM/Université de Montréal

Gail Henderson

University of North Carolina at Chapel Hill

Richard Jefferys

Treatment Action Group

David Margolis*

University of North Carolina at Chapel Hill

Melanie Ott

Gladstone Institutes, University of California

Janet Siliciano

John Hopkins University School of Medicine

Martin Tolstrup

Aarhus University

Susana Valente

Scripps Research Institute

Jerome Zack

David Geffen School of Medicine at UCLA

* Co-Chairs

Subgroup 2: Viral reservoirs, immunology of HIV persistence and kill strategies

Name

Post / Region

Galit Alter

The Ragon Institute of MGH, MIT and Harvard

Brigitte Autran

Université Pierre et Marie Curie

Dan Barouch

The Ragon Institute of MGH, MIT and Harvard,

Georg Behrens

Hannover Medical School

Zhiwei Chen

The University of Hong Kong

Giulio Maria Corbelli

Anlaids/EATG

Steven Deeks*

University of California, San Francisco

Daniel Douek*

Vaccine Research Centre, NIAID, NIH

Gail Henderson

University of North Carolina at Chapel Hill

Timothy Henrich

Brigham & Women’s Hospital

Joseph McCune

University of California, San Francisco

* Co-Chairs

Subgroup 3: Models for HIV cure or sustainable remission

Name

Post / Region

Jintanat Ananworanich*

US Military HIV Research Programme

Serge Eholié

Centre Hospitalier Universitaire de Treichville

Nir Eyal

Harvard University Program in Ethics and Health

Sarah Fidler

Imperial College London

Laurindo Garcia

The B-Change Group

Victor Garcia Martinez

University of North Carolina at Chapel Hill

Jeffrey Lifson*

Leidos Biomedical Research, Inc., NCI at Frederick

Deborah Persaud

John Hopkins Children’s Center

Asier Saez-Cirion

Institut Pasteur

Guido Silvestri

Yerkes National Primate Research Centre, Emory University

* Co-Chairs

Subgroup 4: Gene/cell therapy

Name

Post / Region

Paula Cannon*

University of Southern California

Marina Cavazzana

Hôpital Necker

Hans-Peter Kiem

Fred Hutchinson Cancer Research Center

Daniel Kuritzkes*

Brigham & Women’s Hospital

Keymanthri Moodley

CMEL, Stellenbosch University

Matthew Sharp

HIV Education and Advocacy Consultant

Jan van Lunzen

ViiV Healthcare

* Co-Chairs

Subgroup 5: Novel biomarkers and technologies to analyse/quantify HIV reservoirs

Name

Post / Region

Nicolas Chomont

Université de Montréal

Sharon Lewin*

Doherty Institute for Infection & Immunity, University of Melbourne

John Mellors*

University of Pittsburgh

Monique Nijhuis

University Medical Center Utrecht

Sarah Palmer

Westmead Millennium Institute, University of Sydney

Douglas Richman

University of California, San Diego

Jerome Singh

Nelson R. Mandela School of Medicine

Jeffrey Taylor

CARE Collaboratory Community Advisory Board

* Co-Chairs

Subgroup 6: Social sciences and health system preparedness

Name

Post / Region

Judith Auerbach

University of California, San Francisco

Cynthia Grossman

NIMH, NIH

Ying-Ru Lo*

WHO Regional Office for the Western Pacific

Peter Newman

University of Toronto

Moses Supercharger Nsubuga

Stigmaless

Andrew Phillips

University College London

Bruno Spire

Inserm

Joseph Tucker*

UNC – Project China

Rochelle Walensky

Harvard Medical School,

Ira Wilson

Brown University,

* Co-Chairs